Buy Rating Affirmed: BridgeBio Pharma's Growth Trajectory Bolstered by Strong Pipeline and Strategic Initiatives
TipRanksMay 3 08:35
Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO), Aurinia Pharmaceuticals (AUPH) and 908 Devices (MASS)
TipRanksMay 2 14:22
Strong Buy Rating for BridgeBio Pharma Amid Positive HELIOS-B Study and Promising Infigratinib Developments
TipRanksApr 30 18:17
Maintaining Buy Rating on BridgeBio Pharma: Undervalued Potential of Acoramidis Amid Market Underperformance
TipRanksApr 30 11:35
Buy Rating Affirmed for BridgeBio Pharma on Acoramidis' Positive ATTR-CM Trial Outcomes
TipRanksApr 8 17:46
Buy Rating Justified for BridgeBio Pharma Amidst Promising Long-Term Market Prospects for ATTR-CM Treatments
TipRanksMar 25 09:47
Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO) and Jazz Pharmaceuticals (JAZZ)
TipRanksMar 20 18:10
BridgeBio Pharma Analyst Ratings
BenzingaMar 20 18:26
JP Morgan Maintains Overweight on BridgeBio Pharma, Raises Price Target to $45
BenzingaMar 20 18:28
Cantor Fitzgerald Adjusts Price Target on BridgeBio Pharma to $70 From $60, Maintains Overweight Rating
MT NewswiresMar 19 21:55
BridgeBio Pharma Analyst Ratings
BenzingaMar 19 20:34
Cantor Fitzgerald Maintains Overweight on BridgeBio Pharma, Raises Price Target to $70
BenzingaMar 19 20:35
BridgeBio Pharma Analyst Ratings
BenzingaMar 11 21:14
Cantor Fitzgerald Maintains Overweight on BridgeBio Pharma, Raises Price Target to $60
BenzingaMar 11 21:16
Analysts Have Conflicting Sentiments on These Healthcare Companies: PepGen Inc. (PEPG), BridgeBio Pharma (BBIO) and Amedisys (AMED)
TipRanksMar 7 12:20
BridgeBio Pharma Analyst Ratings
BenzingaMar 5 21:08
Mizuho Maintains Buy on BridgeBio Pharma, Lowers Price Target to $53
BenzingaMar 5 21:09
Analysts Are Bullish on These Healthcare Stocks: BridgeBio Pharma (BBIO), Elevance Health (ELV)
TipRanksMar 5 18:12
Buy Rating Affirmed for BridgeBio Pharma Amidst Strategic Bayer Collaboration and Promising Financial Outlook
TipRanksMar 5 08:06
Maintained Buy Rating for BridgeBio Pharma Amidst Strategic Partnerships and Market Growth Potential
TipRanksMar 5 03:25
No Data
No Data